stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) P/S ratio
As of 5 November 2026, Stevanato Group S.p.A. (STVN) trades at a P/S ratio of 2.5×. Over the past ten years it has ranged from 2.5× (November 2026) to 8.7× (August 2023) — the current reading is the lowest in ten years. That is in line with the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 4.1× | (17.26%) |
| FY2024 | 4.9× | (17.48%) |
| FY2023 | 6.0× | 34.16% |
| FY2022 | 4.5× | (21.37%) |
| FY2021 | 5.7× | 0.68% |
| FY2020 | 5.6× | 0.00% |
| FY2019 | 5.6× | — |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 4.0× | 14.46% |
| Jun 2026 | 3.5× | 28.37% |
| Mar 2026 | 2.7× | (34.10%) |
| Dec 2025 | 4.1× | (24.56%) |
| 22 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| NVST Envista Holdings Corporation compare | 1.4× |
| MMED MiniMed Group, Inc. compare | 1.7× |
| ICUI ICU Medical, Inc. compare | 1.9× |
| STVN Stevanato Group S.p.A. | 2.5× |
| TFX Teleflex Incorporated compare | 2.9× |
| MMSI Merit Medical Systems, Inc. compare | 3.3× |
| WRBY Warby Parker Inc. compare | 3.5× |
| ATRC AtriCure, Inc. compare | 5.0× |
| PLSE Pulse Biosciences, Inc compare | 2,559× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on STVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement